WHO ICTRP trial
An open-label, exploratory, randomised, three-period, six-sequence single dose…
NL-OMON48429 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON48429 |
|---|---|
| Public title | An open-label, exploratory, randomised, three-period, six-sequence single dose crossover study comparing the safety, tolerability and pharmacokinetic profile of a new and marketed flurbiprofen (8.75 mg) spray in healthy male/female subjects under fasting conditions. |
| Scientific title | An open-label, exploratory, randomised, three-period, six-sequence single dose crossover study comparing the safety, tolerability and pharmacokinetic profile of a new and marketed flurbiprofen (8.75 mg) spray in healthy male/female subjects under fasting conditions. - Safety, tolerability and PK… |
| Primary sponsor | Reckitt Benckiser Healthcare (UK) Limited |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Ear, nose and throat diseases Sore throat;Sore throat |
| Interventions | Flurbiprofen 8.75 mg (Mint and Cherry Flavour) spray Flurbiprofen 8.75 mg (Lemongrass and Ginger) spray Flurbiprofen 8.75 mg (Mint and Cherry) spray ;Flurbiprofen;Pharmacokinetic;Safety;Tolerability |
| Registration date | Jan 11, 2019 |
| Target size | 16 |
| Secondary IDs | 2018-003175-36;NL67219.056.18 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: